Evaluation of the Prognostic Value of Solute Carrier Family 34 Member 2 “SLC34A2” in Papillary Thyroid Carcinoma: An Immunohistochemical Study

<div>Kaplan Meier analysis of all PTC cases: overall survival (OS) (a) and disease-free survival (DFS) (b).</div>

Analytical Cellular Pathology

fig3

Figure 3

Figure 3: Evaluation of the Prognostic Value of Solute Carrier Family 34 Member 2 “SLC34A2” in Papillary Thyroid Carcinoma: An Immunohistochemical Study 

Figure 3 | Evaluation of the Prognostic Value of Solute Carrier Family 34 Member 2 “SLC34A2” in Papillary Thyroid Carcinoma: An Immunohistochemical Study 